» Articles » PMID: 28720125

Profiling of the Perturbed Metabolomic State of Mouse Spleen During Acute and Chronic Toxoplasmosis

Overview
Journal Parasit Vectors
Publisher Biomed Central
Date 2017 Jul 20
PMID 28720125
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Toxoplasma gondii, a common opportunistic protozoan, is a leading cause of illness and mortality among immunosuppressed individuals and during congenital infections. Current therapeutic strategies for toxoplasmosis are not fully effective at curtailing disease progression in these cases. Given the parasite ability to influence host immunity and metabolism, understanding of the metabolic alterations in the host's immune organs during T. gondii infection may enhance the understanding of the molecular mechanisms that define the pathophysiology of T. gondii infection.

Methods: We investigated the global metabolic changes in the spleen of BALB/c mice at early and late stage of infection with T. gondii using LC-MS/MS-based metabolomics. Multivariate data analysis methods, principal components analysis (PCA) and partial least squares discriminant analysis (PLS-DA), were used to identify metabolites that are influenced by T. gondii infection.

Results: Multivariate analyses clearly separated the metabolites of spleen of infected and control mice. A total of 132 differential metabolites were identified, 23 metabolites from acutely infected versus control mice and 109 metabolites from chronically infected versus control mice. Lipids, hormones, lactones, acids, peptides, antibiotics, alkaloids and natural toxins were the most influenced chemical groups. There were 12 shared differential metabolites between acutely infected versus control mice and chronically infected versus control mice, of which 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol was significantly upregulated and ubiquinone-8 was significantly downregulated. Major perturbed metabolic pathways included primary bile acid biosynthesis, steroid hormone biosynthesis, biotin metabolism, and steroid biosynthesis, with arachidonic acid metabolism being the most significantly impacted pathway. These metabolic changes suggest a multifactorial nature of the immunometabolic responses of mouse spleen to T. gondii infection.

Conclusions: This study demonstrated that T. gondii infection can cause significant metabolomic alterations in the spleen of infected mice. These findings provide new insights into the molecular mechanisms that underpin the pathogenesis of T. gondii infection.

Citing Articles

Trichinella spiralis -induced immunomodulation signatures on gut microbiota and metabolic pathways in mice.

Sun X, Hao C, Wu A, Luo Z, El-Ashram S, Alouffi A PLoS Pathog. 2024; 20(1):e1011893.

PMID: 38166140 PMC: 10786400. DOI: 10.1371/journal.ppat.1011893.


Establishment of a murine model of congenital toxoplasmosis and validation of a qPCR assay to assess the parasite load in maternal and fetal tissues.

Souza J, Farani P, Ferreira B, Barbosa H, Menna-Barreto R, Moreira O Front Microbiol. 2023; 14:1124378.

PMID: 36922978 PMC: 10009190. DOI: 10.3389/fmicb.2023.1124378.


Histopathological, Immunohistochemical and Biochemical Studies of Murine Hepatosplenic Tissues Affected by Chronic Toxoplasmosis.

Yahia S, Etewa S, Saleh N, Mohammad S, Aboulfotouh N, Kandil A J Parasitol Res. 2022; 2022:2165205.

PMID: 35755604 PMC: 9225867. DOI: 10.1155/2022/2165205.


Immune response against toxoplasmosis-some recent updates RH: immune response.

Sana M, Rashid M, Rashid I, Akbar H, Gomez-Marin J, Dimier-Poisson I Int J Immunopathol Pharmacol. 2022; 36:3946320221078436.

PMID: 35227108 PMC: 8891885. DOI: 10.1177/03946320221078436.


Toxoplasma gondii induces metabolic disturbances in the hippocampus of BALB/c mice.

Ma J, He J, Wang M, Hou J, Elsheikha H, Zhu X Parasitol Res. 2021; 120(8):2805-2818.

PMID: 34219189 DOI: 10.1007/s00436-021-07222-8.


References
1.
Daynes R, Araneo B, Hennebold J, Enioutina E, Mu H . Steroids as regulators of the mammalian immune response. J Invest Dermatol. 1995; 105(1 Suppl):14S-19S. DOI: 10.1111/1523-1747.ep12315187. View

2.
Yarovinsky F . Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014; 14(2):109-21. DOI: 10.1038/nri3598. View

3.
Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, Gomez-Ariza J . Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease. Electrophoresis. 2014; 36(4):577-87. DOI: 10.1002/elps.201400450. View

4.
Hill D, Chirukandoth S, Dubey J, Lunney J, Gamble H . Comparison of detection methods for Toxoplasma gondii in naturally and experimentally infected swine. Vet Parasitol. 2006; 141(1-2):9-17. DOI: 10.1016/j.vetpar.2006.05.008. View

5.
Holmes E, Wilson I, Nicholson J . Metabolic phenotyping in health and disease. Cell. 2008; 134(5):714-7. DOI: 10.1016/j.cell.2008.08.026. View